Activation of Aryl Hydrocarbon Receptor Suppresses Acute Rejection in Allogeneic Cardiac Transplantation

CAI Lanjun,YU Daowu,GAO Yi,YANG Chao,ZHOU Hongmin,CHEN Zhonghua

DOI: https://doi.org/10.14188/j.1671-8852.2013.03.004

2013-01-01

Abstract:Objective: To verify whether activation of the aryl hydrocarbon receptor(AHR) with 2,3,7,8-tetrachlorodibenzo-p-dioxin(TCDD) could expand regulatory T cell subgroup and suppress acute cardiac allograft rejection.Methods: Mouse allogeneic cardiac transplantation from BALB/c(H-2d) to C57BL/6(H-2b) was performed with TCDD/PBS treatment to investigate the severity of acute rejection and the survival of allografts.In vitro,we performed lymphocyte proliferation assay to evaluate the selective expansion effect of TCDD on Treg cells.Phenotype of T cells or expression of IL-10 in recipients was measured by flowcytometry or enzyme linked immunosorbent assay.Results: Activation of the AHR with TCDD significantly suppressed the acute rejection and prolonged the survival of allografts(MST = 23.5 ± 7. 7 days).TCDD expanded the subgroup of CD4 + CD25 + Foxp3 + regulatory T cells in vitro(15.3% ± 2. 6% vs 4.7% ± 2.4% in PBS group,P < 0.01),as well as in spleens and allografts of recipients in vivo(P <0.05).The expression of IL-10 was significantly elevated by the activation of the AHR.Conclusion: Activation of the AHR with single dose of TCDD significantly suppressed acute rejection of allografts,which was associated with the induction of Treg cells by TCDD.